2009 Vienna - European Society of Human Genetics
2009 Vienna - European Society of Human Genetics
2009 Vienna - European Society of Human Genetics
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Keyword Index<br />
P11.013, P11.014, P11.071, S12.3<br />
candidate gene: P16.02<br />
Candidate genes: P08.20, P09.125<br />
canine melanocortin-4 receptor gene:<br />
P09.023<br />
cannabis: P10.19<br />
Canton Sarajevo residents: P10.88<br />
Capability: P01.23<br />
capillary electrophoresis: P02.194, P05.09,<br />
P05.17, P11.077<br />
CAPN3: P16.45, P16.46<br />
capture: P11.035<br />
carbamazepine: P17.65<br />
carcinoma in situ cells: P06.025<br />
Cardiac arrhythmia: P16.15<br />
Cardiac genetics: P16.07<br />
cardiac: C02.2, P16.06<br />
cardi<strong>of</strong>aciocutaneous syndrome: P02.139<br />
cardiogenetics: P16.16, S03.1<br />
Cardiomyopathy: P16.08, P16.10, P16.17,<br />
P16.28, S03.3<br />
cardiovascular disease: P08.18, P17.26,<br />
P17.44<br />
Cardiovascular malformations: P11.015<br />
cardiovascular: P03.182, P09.091<br />
Cardivascular disease: C17.3<br />
carer: P01.33<br />
caries: P08.67<br />
carotid atherosclerosis: P17.25<br />
carrier status: P01.37<br />
carrier: P10.35<br />
Case Report: P02.102<br />
Case studies: P11.082<br />
case-control association study: P09.110<br />
case-control study: P08.19, P10.04<br />
Cataract: P12.117<br />
CATARACTS: P02.165<br />
Catechol-O-methyltransferase: P10.10<br />
Caudal appendage: P03.106<br />
Caveolin-1: P09.024<br />
CBAVD/CUAVD syndromes: P02.119<br />
cbl: S11.1<br />
cblF: P13.08<br />
CD244: P09.109<br />
CD44: P09.031<br />
CDG type Ia: P12.028<br />
CDH1 Deletions: P06.044<br />
CDH1 MLH1 MSH2: P06.034<br />
CDH1-160 polymorphism: P06.035<br />
CDK5R1: P11.016<br />
CDKL5: P02.183, P02.187, P02.188,<br />
P02.189, P02.192<br />
CDKN1C: P03.149<br />
celiac disease: C09.1, P02.096, P09.025,<br />
P12.029<br />
celiac: C17.5<br />
cell cycle: P05.07, P06.082<br />
cell free DNA: P05.08<br />
cell free fetal DNA: P05.09<br />
cell-free fetal nucleic acids: S09.2<br />
Celtic heritage: P10.89<br />
Centa2 and Suz12: P11.015<br />
Centaurin-alpha2: P11.017<br />
centronuclear myopathy: P16.38<br />
cerebellar ataxia: P12.030<br />
cerebellar atrophy: P02.055<br />
cerebral malformation: P02.047<br />
cerebral palsy: P14.04<br />
cerebral small vessel disease: P17.21<br />
Ceruloplasmin: P17.51<br />
cervical cancer, genes: P07.05<br />
cervical cancer: P11.058<br />
Cervical carcinoma: P06.026<br />
Cervival intraepithelial neoplasia: P06.047<br />
CF: P02.131<br />
CFTR gene mutations: P02.119<br />
CFTR gene: P02.123, P03.198<br />
cftr variants: P02.129<br />
CFTR: P02.117, P02.120, P02.122,<br />
P02.124, P02.131, P03.191, P11.018,<br />
P11.050, P15.03<br />
CGD: P12.031<br />
CGG repeats: P03.154<br />
CGH: P03.166, P12.026<br />
CGH-array: P03.089, P06.112, P06.159<br />
CHAPERONE: P12.067<br />
Charcot-Marie-Tooth disease: P16.33<br />
Charcot-Marie-Tooth: P16.35<br />
CHARGE syndrome: P02.017<br />
CHD7: P02.017<br />
cheilognathopalatoschisis: P05.29<br />
CHEK2 mutations: P06.114<br />
CHEK2: P06.124<br />
chemotherapy: P06.141<br />
Chernobyl NPP: P07.02<br />
Cherubism: P02.018<br />
CHIARI I: P12.032<br />
child: P02.015, P02.149<br />
Childhood acute lymphoblastic leukemia:<br />
C06.6<br />
childhood BCP-ALL: P06.199<br />
childhood: P16.23<br />
Children: P01.16, P03.033, P05.44,<br />
P05.49, P06.169, P08.16<br />
Chimeric antigen receptor: P06.091<br />
chimerism: P11.019<br />
Chinese: P12.044<br />
CHM: P12.034<br />
Choice <strong>of</strong> spouse: P10.09<br />
cholesterol: P13.20<br />
chondrodysplasia: P12.033<br />
Choroideremia: P12.034<br />
Chr 7 and 8: P06.190<br />
CHRNA7: C02.3, P03.174<br />
chromium: P03.013<br />
chromosomal aberrations: P03.014,<br />
P03.053, P03.109, P04.25<br />
Chromosomal Abnormalities: C18.5,<br />
P02.074, P03.034, P03.122, P06.184,<br />
P06.185<br />
Chromosomal alterations: P03.009,<br />
P03.039, P03.044<br />
chromosomal anomaly: C07.6, P03.098<br />
chromosomal deletion: P03.129<br />
chromosomal diseases: P05.28<br />
chromosomal mosaicism: P03.054<br />
chromosomal rearrangement: P03.008<br />
chromosomal studies: P03.031<br />
chromosomal translocation: P03.119<br />
chromosomally unbalanced sperm: P04.08<br />
chromosome 10: P03.121<br />
chromosome 15: P08.59<br />
chromosome 18: P03.090<br />
chromosome 2p: P03.036<br />
chromosome 4: P02.005<br />
chromosome 6: P03.162<br />
chromosome 8: P07.04<br />
chromosome 9: P08.46<br />
Chromosome aberations: P03.015<br />
chromosome aberrations: C11.1<br />
chromosome abnormalities: P04.06<br />
chromosome alterations: P03.026<br />
Chromosome instability: P03.004, P03.135<br />
Chromosome organization: P03.006<br />
chromosome study: P06.186<br />
chromosome territory: C16.1<br />
chromosome Y: P03.189<br />
chromosome: C16.4, P03.010, P06.103,<br />
P12.041<br />
chromosomes: P03.169<br />
chromosomopathies: P03.120<br />
Chromsome 17q24: P03.091<br />
chronic cervicitis: P06.022<br />
chronic granulomatous disease: P12.114<br />
chronic heart failure: P17.30<br />
chronic lymphocytic leukaemia: P06.202<br />
chronic lymphocytic leukemia: P06.170,<br />
P06.187<br />
chronic myeloid leukemia Ph1+: P06.191<br />
chronic myeloid leukemia: P06.188,<br />
P06.189, P06.190, P06.201<br />
chronic pancreatitis: P12.035<br />
chrosomal aberration <strong>of</strong> fetus: P05.24<br />
Chuvashiya: P10.44<br />
ciliary disorders: P12.036<br />
ciliopathy: C03.2, P02.019<br />
cirrhosis: P12.004<br />
cis acting elements: P08.11